Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients

Published:2014-10-20 Issue:5 Volume:78 Page:950-960
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Broeyer Frederik J. F.¹,Osanto Susanne²,Suzuki Jun³,de Jongh Felix⁴,van Slooten Henk⁵,Tanis Bea C.⁶,Bruning Tobias⁷,Bax Jeroen J.²,Ritsema van Eck Henk J.⁸,de Kam Marieke L.¹,Cohen Adam F.¹^ORCID,Mituzhima Yutaka³,Burggraaf Jacobus¹

Affiliation:

1. Centre for Human Drug Research; Leiden The Netherlands

2. Leiden University Medical Center; Leiden The Netherlands

3. LLT-Biopharma; Tokyo Japan

4. Ikazia Ziekenhuis; Rotterdam The Netherlands

5. Diaconessenziekenhuis; Leiden The Netherlands

6. Groene Hart ziekenhuis; Gouda The Netherlands

7. Maasstad Ziekenhuis; Rotterdam The Netherlands

8. Advanced Medical Systems; Maasdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12429/fullpdf

Reference44 articles.

1. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials;Swain;Cancer,2003

2. Risk factors for doxorubicin-induced congestive heart failure;Von Hoff;Ann Intern Med,1979

3. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients;Ryberg;J Natl Cancer Inst,2008

4. Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy;Broeyer;J Cancer Res Clin Oncol,2008

5. Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone;Nakamae;Cancer,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating BNIP3-Mediated mitochondrial dysfunction;Redox Biology;2024-06

2. Gossypin Regulated Doxorubicin-Induced Oxidative Stress and Inflammation in H9c2 Cardiomyocyte Cells;Medical Records;2024-01-31

3. Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity;Frontiers in Molecular Biosciences;2023-08-03

4. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway;Phytomedicine;2023-08

5. Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology;Current Oncology Reports;2022-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3